Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36455168

Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Mar 1
First author
Qin S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Jun 1;41(16):3074-3075. doi: 10.1200/JCO.23.00072.
    note
    Source null
    related pmid
    37015029
    relationship
    Comment in

Authors and identifiers

  1. name
    Qin S
    type
    Author
  2. name
    Chen Z
    type
    Author
  3. name
    Fang W
    type
    Author
  4. name
    Ren Z
    type
    Author
  5. name
    Xu R
    type
    Author
  6. name
    Ryoo BY
    type
    Author
  7. name
    Meng Z
    type
    Author
  8. name
    Bai Y
    type
    Author
  9. name
    Chen X
    type
    Author
  10. name
    Liu X
    type
    Author
  11. name
    Xiao J
    type
    Author
  12. name
    Ho GF
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Qin S
    type
    Author
  2. name
    Chen Z
    type
    Author
  3. name
    Fang W
    type
    Author
  4. name
    Ren Z
    type
    Author
  5. name
    Xu R
    type
    Author
  6. name
    Ryoo BY
    type
    Author
  7. name
    Meng Z
    type
    Author
  8. name
    Bai Y
    type
    Author
  9. name
    Chen X
    type
    Author
  10. name
    Liu X
    type
    Author
  11. name
    Xiao J
    type
    Author
  12. name
    Ho GF
    type
    Author
bibliography ids
  1. nci-bib-fb56d30b71a5d4c2aae63e62
book metadata
content sha256
a2e53da998c700253dbfcd313029a1cea6aa1a56bc1f6f0db80c22d79b809234
document type
citation
dois
  1. 10.1200/JCO.22.00620
electronic publication date
display
2022 Dec 1
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36455168
immutable id
pubmed:36455168@a2e53da998c700253dbfcd313029a1cea6aa1a56bc1f6f0db80c22d79b809234
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
7
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1434-1443
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Jun 1;41(16):3074-3075. doi: 10.1200/JCO.23.00072.
    note
    Source null
    related pmid
    37015029
    relationship
    Comment in
outcomes validated
false
pmid
36455168
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
727ec6358f7920448d488654ed5e9f943c2d1c0d079bedbf2da9266d102386d6
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Mar 1
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Clinical Trial, Phase III
  3. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36455168/
title
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial.

Preserved source evidence · Not medical advice